• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - COSTA RICA (COYOL) POLARIS¿ ULTRA; STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - COSTA RICA (COYOL) POLARIS¿ ULTRA; STENT, URETERAL Back to Search Results
Model Number M006192142050
Medical Device Problem Code Calcified (1077)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/02/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Although the suspect device has been received, the evaluation has not been completed.Therefore, the cause of the reported malfunction has not been determined.Upon completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
 
Event or Problem Description
It was reported to boston scientific corporation that a polaris¿ ultra ureteral stent was implanted in the ureter on (b)(6) 2016 and was removed during a ureteroscopy procedure performed on (b)(6) 2017.According to the complaint, during stent withdrawal, the stent was noted to be calcified.The procedure was completed with another polaris¿ ultra ureteral stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Additional Manufacturer Narrative
A visual analysis of the returned device found residues of calcification at renal pigtail and middle section of the stent.The evaluation revealed that the stent was calcified.During manufacturing, devices were inspected to ensure that all finished devices meet specifications.Most likely, the issue could have been generated when the device remains in the patient's body for a certain time.Therefore, the most probable root cause assigned to the complaint is "anticipated procedural complication." a review of the device history record (dhr) confirms that the accepted device met all manufacturing specifications.A search of the complaint database confirmed that no similar complaints exist for the specified batch.
 
Event or Problem Description
It was reported to boston scientific corporation that a polaris¿ ultra ureteral stent was implanted in the ureter on (b)(6) 2016 and was removed during a ureteroscopy procedure performed on (b)(6) 2017.According to the complaint, during stent withdrawal, the stent was noted to be calcified.The procedure was completed with another polaris¿ ultra ureteral stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POLARIS¿ ULTRA
Common Device Name
STENT, URETERAL
Manufacturer (Section D)
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
2546 first street
propark free zone
alajuela
CS 
MDR Report Key6421020
Report Number3005099803-2017-00770
Device Sequence Number16294531
Product Code FAD
UDI-Device Identifier08714729798989
UDI-Public(01)08714729798989(17)20190331(10)19450304
Combination Product (Y/N)N
PMA/510(K) Number
K010002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2017
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Physician
Device Expiration Date03/31/2019
Device Model NumberM006192142050
Device Catalogue Number192-142-05
Device Lot Number19450304
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/13/2017
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 02/28/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date03/21/2017
Supplement Report FDA Received Date04/12/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age40 YR
-
-